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Onosma bracteata Wall. (Boraginaceae) is a highly valuable medicinal herb that is used for
the treatment of fever, bronchitis, asthma, rheumatism, stomach irritation, and other
inflammatory disorders. The present study aims to explore the hepatoprotective potential
of ethanolic extract (Obeth) fromO. bracteata aerial parts against carbon tetrachloride (CCl4)
which causes hepatic damage in the male Wistar rats. Obeth showed effective radical
quenching activity with an EC50 of 115.14 and 199.33 µg/mL in superoxide radical
scavenging and lipid peroxidation analyses respectively along with plasmid DNA
protective potential in plasmid nicking assay. The Obeth modulated mutagenicity of 2
Aminofluorine (2AF) in the pre-incubation mode of investigation (EC50 10.48 µg/0.1 mL/
plate) in TA100 strain of Salmonella typhimurium. In in vivo studies, pretreatment of Obeth
(50, 100, and 200 mg/kg) had the potential to normalize the biochemical markers
aggravated by CCl4 (1mL/kg b.wt.) including liver antioxidative enzymes.
Histopathological analysis also revealed the restoration of CCl4-induced liver
histopathological alterations. Immunohistochemical studies showed that the treatment of
Obeth downregulated the expression levels of p53 and cyclin D in hepatocytes. and
downregulation in the Western blotting analysis revealed the downregulation of p-NF-kB,
COX-2, and p53. HPLC data analysis showed the supremacy of major compounds namely,
catechin, kaempferol, epicatechin, and Onosmin A in Obeth. The present investigation
establishes the hepatoprotective and chemopreventive potential of O. bracteata against
CCl4-induced hepatotoxicity via antioxidant defense system and modulation of the
expression of proteins associated with the process of carcinogenesis in hepatic cells.
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Global increase in the demand of industrial solvents in
pharmaceuticals, paint and coating industry can raise the
global solvent market to an estimated USD 12.31 billion by
year 2026 as per Global Market Outlook report (2018). Recently,
the use of industrial solvents has brought higher risks to both
humans and animals. Industrial solvents cause environmental
pollution and their acute and chronic exposure can cause cellular
injuries and progressive genetic alterations (mutations) via
activation of reactive oxygen species (ROS) with significant
changes that may transform healthy cells to cancerous cells
(Pizzino et al., 2017). The mutations caused alter the DNA
which along with oxidative stress triggers destruction of
tumor-suppressor genes and/or the stimulation of proto-
oncogenes which contribute to the initiation of liver, breast,
colon and prostate cancer (Maron and Ames, 1983; Canli
et al., 2017).
The liver is the main organ essential for survival, which plays
a crucial function in the body’s metabolism and detoxification
process. The liver is a primary site in the body that is mostly
involved in modulation and biotransformation of xenobiotic
compounds mediated by cytochrome P450 (CYP) family of
enzymes (Gu and Manautou, 2012). The chemicals like carbon
tetrachloride (CCl4), acetylaminofluorene, thioacetamide, and
polycyclic aromatic hydrocarbons are biotransformed into the
transitional molecules and generate reactive oxygen species
(ROS), including oxygen free radicals that induce hepatic
damage (Karakus et al., 2011; Kaur et al., 2017; Kaur S. et al.,
2019). Various hepatotoxic compounds and transitional radicals
of oxidative reactions affect many proteins and encourage
negative effects via oxidative stress (OS) or DNA damage
(Rahal et al., 2014). The homeostatic balance of cellular redox
is the main feature for combating the lethal insults of ROS, which
are internally maintained by antioxidative defense systems. Any
aberrant functioning to curb stress can lead to malfuctioning like
cancer (Snezhkina et al., 2019). Carbon tetrachloride (CCl4) is a
typical solvent which is used in the research for hepatic ailments.
Firstly, liver can metabolize CCl4 by cytochrome P450 enzyme
complex to produce toxic metabolites such as trichloromethyl
free radicals (CCl3
•) and trichloromethyl peroxyl radicals
(CCl3OO
•). These free radicals have capacity of eliminating
hydrogen ions from fatty acids to induce lipid peroxidation.
Hence, mutually CCl3
• and CCl3OO
• cause injury in the cell
membrane, alteration in enzyme action and lastly cause hepaticAbbreviations: 2AA, 2-aminoanthracene; 2-AF, 2-aminofluorene; AA, Ascorbic
acid; BC, bacterial culture; b.wt., body weight; CCl4, carbon tetrachloride; COX-2,
cyclooxygenase-2; CPCSEA, committee for the Purpose of Control and
Supervision of Experiments on Animals; ANOVA, analysis of variance. CYP,
cytochrome P450; df, Degree of freedom; EDTA, ethylenediamine tetraacetic acid;
ECL, Enhanced chemiluminescence; FeCl3, Ferric chloride; GSH, reduced
glutathione; GSSG, oxidized glutathione; HPLC, high-performance liquid
chromatography; i.p, intraperitoneal; MDA, malondialdehyde; NBT, nitro blue
tetrazolium; NF-kB, nuclear factor-kappaB; NPD, 4- Nitro-o-phenylenediamine;
PAGE, polyacrylamide gel electrophoresis; PBS, phosphate buffer saline; PMS,
Phenazine methosulfate; PVDF, polyvinylidene fluoride; ROS, reactive oxygen
species; rpm, revolutions per minute; SA, sodium azide; SDS, sodium dodecyl
sulphate; TA, top agar; TCA, trichloroacetic acid; WB, western blotting.
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cancer still is one of the important tasks despite the newest
developments in recognizing its biological basis. The
deregulation of p53, COX-2, and NF-kB signaling is one of the
central factors for the beginning of hepatic cancer (Alqahtani
et al., 2019). p53 (a tumor suppressor gene) associated mutations
are found in most of the hepatocellular carcinoma (HCC)
(Aravalli et al., 2008). From the past few decades, the natural
phytoconstituents from plants are recognized for restoring the
health of humans (Che and Zhang, 2019). So, the diet rich in
natural compounds has been shown to exert various healing
effects via activating redox-signaling, phase-II detoxification
enzymes, antioxidants, anti-inflammatory, and anti-carcinogenic
properties (Wu et al., 2017).
Onosma bracteata Wall. family Boraginaceae widely knowns
as ‘gaozaban’ is mainly distributed in India and Nepal in high
altitude regions, spread in Jammu & Kashmir, Himachal Pradesh
and Uttar Pradesh in north-western Himalayas (Ved et al., 2016).
It is used as the main component for the preparation of drug in
Unani and Ayurvedic medicinal system. It is usually used in Indian
traditional medication due to its medicinal benefits viz. demulcent,
diuretic, anti-aging, antioxidant, antibacterial, wound healing,
antileprotic, spasmolytic, and tonic nature (Fareed et al., 2012).
The entire parts ofO. bracteata have pharmacological properties like
anthelmintic, anti-inflammatory, antimicrobial, antiperoxidative,
and radical scavenging (Albaqami et al., 2018; Imran et al., 2018;
Farooq et al., 2019). It is reported thatOnosma genus is a rich source
of flavonoids, benzoquinones, naphthoquinones, shikonins, and
onosmins (Kumar et al., 2013). However, to date, there are no
records about its hepatoprotective activity.
Thus, we planned to explore the protective effects of Obeth
from O. bracteata by using in vitro assays viz. antioxidant,
antimutagenic and DNA protective potential. Further, in vivo
studies were carried out to explore the hepatoprotective effects of
Obeth via evaluation of serum marker enzymes, antioxidative
enzymes and histopathological parameters. Modulatory effects
on the expression level of p53, COX-2, NF-kB, and Cyclin D
were studied using immunohistochemical (IHC) and
Western blotting.MATERIALS AND METHODS
Chemical and Reagents
1-chloro-2, 4- dinitrobenzene (CDNB), 2- thiobarbituric acid
(TBA), 5, 5-dithiobisnitrobenzoic acid (DTNB), Bovine
Serum Albumin (BSA), Hydrogen peroxide (H2O2),
malondialdehyde, nitro blue tetrazolium (NBT), and Silymarin
were procured from Sigma (St. Louis, MO, USA). Carbon
tetrachloride (CCl4), ethidium bromide (EtBr), low melting
point agarose (LMPA), malondialdehyde (MDA), nicotinamide
adenine dinucleotide (NADH), normal melting point agarose
(NMPA), hydroxylamine hydrochloride, oxidized glutathione
(GSSG), phenazine methosulfate (PMS), reduced glutathione
(GSH), sodium pyruvate, and xylenol orange were obtained
from HiMedia Pvt. Ltd., (Mumbai, India). The pBR322August 2020 | Volume 11 | Article 1301
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India. Cyclin-D (cyclin-dependent), p53 (tumor suppressor p53),
COX-2, and Nf-kB antibodies were purchased from Cell
signaling technology (Danvers, MA, USA). (PVDF) membrane
(MDI, Ambala), ECL kit was procured from (Biorad, USA). Kits
for analysis of serum parameters were purchased from Erba
Mannheim (London, UK). The other chemicals used in the
experiments were of Analytical grade.
Collection, Identification, and
Authentication of Plant Material
The aerial parts including stems and leaves of Onosma bracteata
Wall. were collected from Herbal Health Research Consortium
(HHRC) Pvt. Ltd. Amritsar, Punjab (India), a Government of
India approved Drug analysis laboratory. Mr. Viney (Research
Officer), at the HHRC Pvt, Ltd. identified and authenticated the
plant material by analyzing organoleptic, microscopic and
pharmacognostic characteristics. The specimen with accession
no: GAZ-03 was submitted in the herbarium of HHRC Pvt. Ltd.
Amritsar, Punjab (India).
Extraction Procedure
The plant material was washed with running tap water and dried
at 40°C. The material was crushed to powder form (2 Kg) and
soaked with 80% ethanol by using the maceration method. The
filtered material was evaporated using Rotavapor (Buchi
Rotavapor R-210, Switzerland) and was dried to yield 120 g
(6%) of the ethanolic extract (Obeth).
Antioxidant Assays
Superoxide Radical Anion Scavenging Assay
The radical scavenging activity of Obeth was conducted according
to the method suggested by Nishikimi et al. (1972), with little
modifications. Initially, 0.06 M NBT and 0.156 M NADH were
mixed to the different Obeth concentrations (25–400 mg/mL),
along with the addition of 0.468 M PMS. In the control samples,
Obeth was substituted by methanol in all of the above solutions.
The mixtures were kept at room temperature for 20 min. In the
incubation phase, the yellow-colored NBT was reduced to blue
colour and the absorbance was recorded at 560 nm.
The percentage decrease of NBT was represented as:
Percent change = ((ODC ODS)=ODC) 100
where ODC = Absorbance of control solution.
ODS = Absorbance of the sample solution.
Lipid Peroxidation (TBARS) Assay
For this experiment, the procedure was adopted as proposed by
Halliwell and Gutteridge (1989), with a little amendment. The
lipid origin (10% homogenous egg), 150 mM KCl, and Obeth
(25–400 mg/mL) were combined in this assay. In place of Obeth,
methanol was used as a control. To continue lipo-oxidation to
the above reaction mixture, 10 mM FeCl3 was added followed by
incubation at 37°C for 30 min. Subsequently, HCl solution
(comprising TCA, TBA and BHT) was added to the mixture
and the resultant mixture was heat treated for 1 h at 90°CFrontiers in Pharmacology | www.frontiersin.org 3accompanied by cooling and centrifugation at 2,500 rpm for
15 min. Lastly, the absorbance of pink coloured supernatant
formed was recorded at 532 nm.
The estimation of the percent inhibition (anti-lipoperoxidation
activity) was based on the formula below:
Percent change = ((ODC-ODS)=ODC) 100
where ODC = Absorbance of control solution.
ODS = Absorbance of the sample solution.
Plasmid Nicking Assay
To determine the DNA protective ability of Obeth or capacity to
scavenge the hydroxyl radical (•OH), the plasmid nicking assay
was conducted as per the procedure given by Lee et al. (2002) with
few amendments recommended by Robin et al. (2015). Different
concentrations (25–100 μg/mL) of Obeth from O. bracteata were
mixed with freshly prepared Fenton’s reagent (30 mM H2O2, 50
mMAscorbic acid, and 80 mM FeCl3) and pBR322 plasmid DNA,
followed by incubation for 30 min at 37 °C. The samples were
resolved onto 1% (w/v) agarose gel using electrophoresis unit at
60 V for 1 h. For this assay, rutin (100 μg/mL) was used as a
standard. Immediately, DNA bands were viewed with Gel Doc XR
(Bio-Rad, USA), and the band density was determined by using
LabImage Bioimaging Platform (Version: 4.1.1) software.
Antimutagenic Activity
The antimutagenic potential of Obeth from O. bracteata was
studied using Ames test, with two Salmonella typhimurium
strains as per the method given by Maron and Ames (1983)
with few amendments recommended by Kaur et al. (2000). The
strains of S. typhimurium were procured from Microbial Type
Culture Collection (MTCC), Chandigarh. Under sterile conditions,
direct-acting mutagens, i.e., 4- Nitro-o-phenylenediamine and
sodium azide were used for TA98 and TA100, respectively. The
antimutagenic activity of Obeth, at different concentration levels
(25–250 mg/0.1 mL/plate), was studied using two experimental
approaches viz. co-incubation and pre-incubation modes to
distinguish between the bio-antimutagenicity and desmutagenicity,
respectively. Negative control contains only bacterial culture, Obeth
and top agar which showed that Obeth did not exhibit mutagenic
characteristics. In co-incubation mode, mutagen with Obeth was
blended into 2mL of top agar containing bacterial culture whereas,
in pre-incubation, the mixture ofObeth and mutagen was incubated
at 37 °C for 30 min before adding to the top agar with bacterial
culture. The positive control contains bacterial culture andmutagens
which help to assess the dosage rate of toxicity/mutagenicity. Obeth
antimutagenicity was also tested using S9-mix in the top agar as per
the procedure suggested by Garner et al. (1972). The protocol
includes a similar method as previously mentioned, except with
the inclusion of S9-mix among other components of top agar for the
activation of indirect acting mutagens. The reverting colonies were
counted using a colony counter.
Antimutagenic Effect
Antimutagenic activity is defined by the percentage decrease in
the number of colonies as shown below:August 2020 | Volume 11 | Article 1301
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= (a-b)=(a-c) 100
where,
a= number of mutagenic-induced colonies (positive control)
b= number of colonies induced with mutagen and different
concentration of Obeth
c= number of colonies in (negative control).
Hepatoprotective Activity
Animal Ethics Statement
This experiment was performed in compliance with the guideline
of the Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSE), Ministry of Environment
and Forestry, Government of India, and authorized by
Institutional Animal Ethics Committee (IAEC), GNDU
(approval number 226/CPCSEA/2014/06). As indicated by the
IAEC, all rats were entitled to humane care.
Procurement and Care of Experimental Animals
Male Wistar rats, weighing between 150–240 g were purchased
from the National Institute of Pharmaceutical Education and
Research (NIPER), S.A.S. Nagar, Mohali, Punjab (India). The
acclimatization of rats was conducted for one week in
polypropylene cages containing husk in the aerated Central
Animal House of Guru Nanak Dev University, Amritsar.
Commercial rodent feed was provided for the rats, and water
was given ad libitum with an environmentally regulated
condition (55 ± 5 percent humidity, 23 ± 2° C) with a 12 h
light/dark cycle photoperiod.
Experimental Design
After acclimatization, rats were divided into 7 groups (n=6).
Group, I served as control; Group II intoxicated with 1 mL kg-1
CCl4 (mixed in same volume of olive oil via intraperitoneal (i.p.)
doses, 3 days in a week) which induced liver mutilation and is
mostly used for analyzing the hepatoprotective potential of
various drugs (Ritesh et al., 2015; Zamzami et al., 2019); Group
III was provided pretreatment of 50 mg kg−1 body weight (b.wt.)
of silymarin (natural chemopreventive compound) for 21 days
via oral route accompanied by CCl4 (i.p.) doses, 3 days in week
without fasting of rats; Group IV was administered with an oral
dose of only Obeth (100 mg kg−1 b.wt.) of O. bracteata as
negative control; Group V was provided with the Obeth (50
mg kg−1 b.wt.) accompanied by CCl4 (i.p.) doses; Group VI was
provided Obeth (100 mg kg−1 b.wt.) intoxicated with CCl4;
Group VII was given Obeth (200 mg kg− 1 b.wt.) accompanied
with CCl4 (i.p) treatment. The experimental concentrations of
Obeth have been decided based on the literature report on O.
bracteata in in vivo studies (Asif et al., 2019).
Blood Extraction and Serum Marker
Enzyme Analysis
The rats were kept on fasting overnight before termination of
experiment, the blood was extracted from retro-orbital venous
puncture into heparinized tubes under moderate diethyl-etherFrontiers in Pharmacology | www.frontiersin.org 4anesthesia. The blood samples were centrifuged at 3,000 rpm for
20min for the separation of serum. The extracted serumwas used for
examining the different hepatic markers enzymes (Serum Glutamic
Pyruvic Transaminase (SGPT), Serum Glutamic-Oxaloacetic
Transaminase (SGOT), Alkaline Phosphatase (ALP), total bilirubin,
total protein, Albumin, urea, creatinine, and cholesterol) using Erba
diagnostics kits with Bene Sphera autoanalyzer.
Animal Sacrifice and Preparation of
Liver Homogenate
The liver was dissected after euthanizing by cervical dislocation. The
collected liver was washed with ice-cold saline solution. After this, the
liver was rinsed with the mixture of (150 mM KCl + 10 mM Tris-
HCl) buffer. Finally, 10 percent (w/v) of dried liver homogenate was
mixed with chilled Tris-KCl buffer and centrifugation at 2,500 rpm
for 10 min. Supernatant was separated and used for further analysis.
Biochemical Analysis of Liver Functions
Protein Quantification
The standard protocol given by Bradford, 1976 was used for the
quantification of protein concentration in the liver. In this
experiment, 900 μL of Bradford reagent was mixed with
100 μL of homogenate. The reaction solution was then kept for
30 min at room temperature and the absorbance was calculated
on ELISA plate reader at 595/450 nm.
Estimation of Lipid Peroxidation
To check lipid peroxidation in liver homogenate, TBARS
(thiobarbituric reactive species) procedure recommended by
Devasagayam et al. (1983) was used. 2 mL of TBA solution was
mixed to 500 mL of the sample. The mixture was fully stirred and
incubated for 30 min at 80°C followed by centrifugation for 15 min
at 2,000 rpm. Lastly, supernatant reading was taken at 532 nm and
600 nm. MDA was used as a standard for measuring the amount of
TBARS represented as MDA value (MDA equal mmol/g of tissue).
Estimation of Lipid Hydroperoxides
Lipid hydroperoxide generation in liver homogenate was
assessed as a method proposed by Jiang et al. (1992). 900 μL of
Fox reagent (0.1 M Xylenol orange, 0.025M of H2SO4, 0.25 M of
(NH4)2 Fe(SO4)2.6H2O, and 0.004 M of C15H24O) was mixed to
100 μL of liver homogenate. This reaction mix was kept for
40 min at 37°C and final reading was measured at 560 nm. The
lipid hydroperoxide generation is shown as nMH2O2 equivalent/g
of tissue.
Estimation of Reduced Glutathione
Content (EC1.6.4.2)
The reduced glutathione content in liver homogenate was
detected as per the protocol given by Anderson (1985) with
little changes. Potassium phosphate buffer (200 μM, pH 8) and
DTNB solution (600 μM) were mixed to 100 μL homogenate,
preceded by incubation for 10 min and the absorbance was
recorded at 412 nm. Glutathione was used as a reference for
making a standard curve and total GSH content was expressed as
μmol of GSH content/g of tissue.August 2020 | Volume 11 | Article 1301
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Evaluation of Cytochrome P450 and P420 Content
Phase I enzymes were determined as per the method performed
by Choi et al. (2003). In this protocol, the liver homogenate was
added into two 96-well plates. In one plate 15 mL of sodium
hydrosulphite (500 mM) was added in each well preceded with
30–35 bubbles of carbon monoxide. Another plate was saturated
with only 30–35 bubbles of carbon monoxide without adding
sodium hydrosulphite. The absorbance was observed at 420 nm,
450 nm, and 490 nm.
Cytochrome b5 Analysis
The cytochrome b5 (Cyt b5) quantities were analyzed as the method
suggested by Omura and Sato (1964). In this experiment, 500 μL of
liver homogenate was added to 4.3mL of Tris-HCl buffer. After that,
50 mL of this mixture was poured onto two separate 96-well plates.
Now, 50 mL of NADPH (500 mM) was added in each well of one
plate and 50 mL of Tris-HCl in each well in the other plate followed
by incubation for 20 min. The absorbance was measured at 409 nm
and 424 nm. The enzyme activity was determined by using the
extinction coefficient (6.22 mM1 cm1).
NADPH Cytochrome b5 Reductase
The NADPH Cyt b5 was determined using procedure
recommended by Mihara and Sato (1972) with little modification.
For this, 200 μL of NADPH (100 μM) and 200 μL of Potassium
ferricyanide (200 μM) were mixed with 500 μL of potassium
phosphate buffer (300 mM). The process was initiated with the
addition of 100 μL of homogenate. The NADPH Phase II Enzymes
Glutathione-S-Transferase (EC 2.5.1.18)
Phase II metabolic isozyme glutathione-S-transferase (GST) was
quantified as per the method suggested by Habig et al. (1974). In
this experiment, 2.7 mL of sodium phosphate buffer (100 mM)
was mixed with 100 μL each of 1-Chloro-2,4-dinitrobenzene
(CDNB) (0.03 M) and 100 μL reduced glutathione (0.03 M)
followed by incubation at 37°C for 5 min. After incubation, 100
μL of homogenate was added to initiate the reaction and enzyme
activity was recorded at 340 nm at 30 s interval for 3 min.
Antioxidative Enzymes
Catalase (CAT) (EC 1.11.1.6)
Catalase was analyzed in the liver homogenate as the method
described by Aebi (1984) with little modifications. 300 μL of H2O2
(150 mM) and 2.6 mL of 50 mM potassium phosphate buffer
(50 mM) were mixed thoroughly. After this, homogenate was added
to initiate the reaction. Eventually, the absorbance was recorded for
the catalase activity at an interval of 15 s, for 2 min at 240 nm.
Glutathione Reductase (GR) (EC 1.6.4.2)
A slight modification was done to assess the GR level in the
samples using the protocol given by Carlberg and Mannervik
(1975). In this assay, the reaction mixture was prepared by
adding 1.2 mL of sodium phosphate buffer (200 mM), 200 mL
oxidized glutathione (10 mM), 200 mL EDTA (20 mM), and 200
mL of homogenate. Finally, 200 mL NADPH (1000 μM) was
mixed in a reaction solution and at an interval of 15 s, absorbance
was measured at 340 nm for 3 min.Frontiers in Pharmacology | www.frontiersin.org 5Lactate Dehydrogenase (EC 1.1.1.27)
To determine the lactate dehydrogenase (LDH) activity in liver
homogenate, the protocol recommended by Kaur S. et al. (2019)
with slight modifications was adopted. In this experiment,
reaction mixture comprising of 2.3 mL of Tris HCl buffer (100
mM, pH 7.1), 300 mL of sodium pyruvate (100 mM), 100 mL
Triton X (7.5%), and 300 mL of NADH (3 mM) was incubated at
30°C for 15 min. In this reaction mixer, 100 mL of homogenate
was added and absorbance was measured at an interval of 10 s at
340 nm for 1 min.
Guaiacol Peroxidase (EC 1.11.1.7)
Guaiacol peroxidase activity in liver homogenate was determined
as per the method suggested by Gee et al. (1970) with slight
modifications. The reaction mixture was prepared by adding 75
mL (20 mM) of guaiacol solution to 25 mL 100 mM phosphate
buffer with 100 μL of liver homogenate and then 25 mL of H2O2
was added. The absorbance was taken at 436 nm.
Histopathological Assessment
To check the hepatocytes’ structural integrity, the isolated livers
from the respective groups were fixed in a 10% buffered formalin
solution, dipped in ethanol for dehydration and implanted in
paraffin wax. The microtome was used to make sections of the
livers (0.4 mm thick) using paraffin blocks and stained with H&E
(hematoxylin and eosin) by the standard procedure. The slides
were observed with a Nikon Eclipse E200 Compound microscope.
Immunohistochemical (IHC) Examination
To evaluate the pattern of expression of p53 and cyclin D
proteins (after treatment with CCl4 and Obeth) in hepatocytes,
IHC analysis was performed. In this method, the liver sections
(3-6 mm) were deparaffinized on glass slides. The sections were
kept for 30 min in H2O2 (0.3% of methanol). The section slides
were blocked with 5% skimmed milk for 30 min. Finally, slides
were incubated overnight with anti-p53 and anti-cyclin D
antibodies at 4°C. Slides were then washed twice with 1 x PBS
followed by the addition of anti-rabbit IgG HRP- conjugated
secondary antibody and incubated for 30 min and washed thrice
with 1x PBS. The expression of proteins was developed by using
3-diaminobenzidine (DAB) for 2–3 min and washed with 1 x




The comet assay (single-cell gel electrophoresis) was performed
according to the protocol given by Collins and Dusǐnská (2002)
with slight modifications. In this assay, 500 mg of rat liver was
minced in trypsin solution and kept for 15–20 min at room
temperature. The homogenate was passed through a muslin
cloth to remove tissue debris followed by centrifugation at
2,500 rpm for 10 min to obtain a cell pellet. After that, 50 μL
of cell suspension was added to a low melting point agar (LMPA)
solution and transferred to normal melting point agar (NMPA)
coated glass slides. The slides were kept in the fridge for 10–15August 2020 | Volume 11 | Article 1301
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10 mM Tris-HCl, 1% Triton X-100, 250 mM NaCl, 10 percent
DMSO; pH 10) at 4°C for 3- 4 hr. Now slides were dipped in
electrophoresis buffer for 10-15 min before starting
electrophoresis (voltage = 25 V, current = 300 mA, time =
20 min). After electrophoresis, the slides were dried and kept
in neutralization buffer for 15 min (thrice). After 24 h slides were
stained with 100 mL (20 mg/mL) ethidium bromide and observed
in the fluorescent microscope (Nikon, Tokyo, Japan). Per slide
thirty cells were selected randomly to assess DNA impairment,
tail length, tail DNA (%) and tail moment using Comet Assay
Software Project (CASP) Lab version CASP1.2.3 beta 1.
Western Blot Analysis
The liver was dissected and rapidly stored according to respective
groups at -80°C. The samples were homogenized in RIPA lysis
buffer followed by centrifugation at 12,000 rpm for 20 min and
the upper transparent solution was then poured into new tubes.
The quantity of proteins was analyzed using Bradford method.
Equal concentration of protein (40 mg) was resolved by SDS-
PAGE and transferred to PVDF membrane through western
bloting. After that, the membrane was blocked using BSA (5% in
TBST, 0.1% Tween-20) for 2 h at 25°C and kept overnight with
antibodies against p53 (1:1,000), NFkB (1:2,000) and COX-2
(1:500). After that, the membrane was washed thrice with TBST
and HRP-conjugated secondary antibody (1:1,500) was added
followed by incubation for 2 hr at room temperature. ECL
reagent was used to develop blots and imaging was done using
Image-Quant LAS 4000, GE Healthcare. Band densities were
quantified with Alphaease FC Software (version 4.0). b-actin
(1:500) as endogenous control was used for normalizing the
expression of the protein of interest.
Phytochemical Analysis
HPLC Analysis
The filtered Obeth was analyzed for the presence of polyphenols
using UHPLC Nexera system (Shimadzu, MA, USA), column
(C18). The solvent used in mobile phase consisted of solvent AFrontiers in Pharmacology | www.frontiersin.org 6(0.2% acetic acid) and solvent B (methanol). The flow rate of 1.0
mL/min was sustained for 21 min of running time. The gradient
flow used was: 20% B (0–10 min), 55% B (10–12 min), 70% B
(12–14 min), 50% B (14–15 min), 40% B (15–17 min), and 30% B
(17 –21 min). For testing, the injection volume of the sample was
10 mL with column temperature maintained at 25°C. The spectra
were observed at 280 nm with a photodiode array (PDA)
analyzer. The peaks of the compound were identified by
comparing retention time and distribution of UV-VIS spectra
of samples with those of standard compounds.
Statistical Analysis
All results are represented as Mean ± SE of minimum three
independent replicates. To compare difference among the means,
one-way and two-way analysis of variance (ANOVA) with
Tukey’s test was used at 5% confidence level (p-value ≤ 0.05).RESULTS
Antioxidant Potential of Obeth
Superoxide radical scavenging and lipid peroxidation activity of
Obeth is shown in Figure 1, Table S1. SRS assay there is dose-
dependent increase in free radical scavenging activity via NBT
inhibition with EC50 (115.14 mg/mL) whereas EC50 of Rutin was
observed to be 46.18 μg/mL. The lipid peroxidation activity of
Rutin and Obeth was EC50 (115.68 mg/mL) and EC50 (199.33 mg/
mL) respectively (Table S2) exhibiting Obeth with better
antioxidant activity as compared to standard rutin.
Plasmid Nicking Assay
DNA protective effect of Obeth at various concentrations viz. 25,
50, 100 μg/mL was demonstrated in Figure 2. It was observed
that the Obeth exhibits quite strong radical scavenging properties
with the highest tested concentration (100 mg/mL) on pBR322
plasmid DNA. The experiment exhibited the formation of nicked
DNA because of hydroxyl (•OH) radicals produced by Fenton’sA B
FIGURE 1 | Graphs shows the in vitro antioxidant potential of Obeth from O. bracteata. (A) Superoxide radical scavenging assay. EC50 = 115.14 µg/mL; F-ratio =
187.19; HSD = 8.77. (B) Lipid peroxidation inhibition assay. EC50 = 199.33 µg/mL; F-ratio = 331.68; HSD = 5.89. Values are expressed as Mean ± SE at level of
significance p ≤ 0.05. Data labels with different letters represent significant difference among them.August 2020 | Volume 11 | Article 1301
B
y Fenton’s reagent (FR) in DNA nicking assay. (A) Relative mobility of different forms of plasmid DNA exposed to
sitive control (pBR322 DNA + FR); Lane 3: pBR322 DNA + FR + 100 µg/mL rutin; Lanes 4, 5, 6: pBR322 DNA +







































FIGURE 2 | Effect of Obeth from O. bracteata on DNA protection against oxidative damage caused b
Obeth extract in electrophoresis. Lane 1: Negative control (pBR322 DNA + distilled water); Lane 2: Po
FR + 25, 50, 100 µg/mL Obeth fraction respectively. (B) Densitometric analysis showing relative percentag
and (C) graph respectively (software used = Lab Image). CN = Control, FR=Fenton reagent.
Kumar et al. Hepatoprotective Effects of Onosma bracteata Wallreagent. The various concentrations of Obeth showed a dose-
dependent minimization of supercoiled DNA to open circular.
Ames Assay
The antimutagenic potential of Obeth was tested against sodium
azide and 2-aminofluorene mutagenicity in S. typhimurium
strains as shown in Table S3. The Obeth in TA100 strain (-S9
mix) displayed a high inhibition rate (82.30% at 250 mg/0.1 mL/
plate) showing strong modulation of genotoxicity of base-pair
substitution mutagen sodium azide as compared to NPD (frame-
shift mutagen) in TA98 tester strain Table 1. The Obeth
exhibited high antimutagenicity potential for preincubation
mode than in co-incubation approach without -S9 in both
TA100 and TA98 as shown in Figure 3A and with +S9 mix in
Figure 3B. Minimum EC50 values were depicted by the extract
against 2AF mutagenicity in pre-incubation mode in TA100
strain as shown in Table S3. In case of TA98 strain also, Obeth
showed good antimutagenic potential in pre-incubation
experiments as compared to co-incubation approach (Figure 3,
Table 1). The calculated EC50 value showed the high suppression
of mutagenicity with a minimum EC50 value (29.51 μg/0.1 mL/Frontiers in Pharmacology | www.frontiersin.org 8plate) with TA98 (+S9) in the pre-incubation approach of
treatment as shown in Table S3. The evaluation between all
treatments, with and without S9, is shown in Figure 3, Table S3
respectively. The assessment permits noticeable potential of
Obeth +S9, even at minimum concentrations, as compared to
-S9 treatments. Therefore, the complete investigation showed the
conspicuous activity of Obeth, with S9 mix in pre-incubation
approach. The findings were statistically evaluated by two-way
ANOVA for statistical difference and the interactions as seen in
Table 1, S3. The study revealed a statistically significant difference
between co-incubation and pre-incubationmethods of investigation,
in addition to among different treatments used. So, the Obeth of O.
bracteata exhibited marked antimutagenicity potential.
Variations in Body Weight (b.wt.) of
Animals
In the present study CCl4 treated group, the percentage fold
decrease in b. wt. of rats was recorded after 3 weeks, and a
statistically significant difference was observed in the b.wt. of
CCl4 rats treated group (0.88-fold) relative to control group I
(one-fold). Additionally, dose-dependent variability in the b.wt.TABLE 1 | Percentage inhibition of mutagenicity by Obeth extract of O. bracteata in TA98 and TA100 tester strains of Salmonella typhimurium with and without S9.
Treatment Dose/0.1 mL/plate TA 100 (without S9)
% Inhibition
TA 98 (without S9)
% Inhibition
TA 100 (with S9)
% Inhibition
TA 98 (with S9)
% Inhibition
Co-incubation 25 µg 42.01 ± 4.25b 23.07 ± 3.42c 53.02 ± 5.71c 40.40 ± 3.42c
50 µg 50.69 ± 4.24b 39.92 ± 3.76b 66.85 ± 1.66b 50.35 ± 2.05b
100 µg 65.71 ± 2.48a 50.98 ± 1.65ab 74.48 ± 2.59ab 60.37 ± 1.40a
250 µg 74.47 ± 2.51a 58.97 ± 1.81a 83.37 ± 1.21a 61.51 ± 2.08a
Pre-incubation 25 µg 49.77 ± 2.88c 35.53 ± 2.79c 60.91 ± 2.01c 46.39 ± 2.45c
50 µg 60.51 ± 2.06b 47.60 ± 2.76b 70.66 ± 3.44b 57.74 ± 1.79b
100 µg 75.28 ± 2.91a 58.79 ± 1.74a 85.01 ± 1.11a 73.43 ± 3.45a
250 µg 82.30 ± 1.63a 62.85 ± 3.33a 91.41 ± 1.26a 82.56 ± 2.24aAugust 2020 | Volume 1Values are represented as Mean ± SE, level of significance p ≤ 0.05. Means with different superscripts represent significant difference among them in all groups.A B
FIGURE 3 | Graph represents the antimutagenic potential of Obeth using S. typhimurium in Ames assay. (A) Represents the TA100 and TA98 without S9 (Pre and
Co-incubation). (B) Represents TA100 and TA98 with S9 (Pre and Co-incubation). (A) Represent the percent inhibition between co- and pre-incubation in TA98 and
TA100 strain without S9. (B) Represent the percent inhibition between co- and pre-incubation in TA98 and TA100 strain with S9.1 | Article 1301
Kumar et al. Hepatoprotective Effects of Onosma bracteata Wallof Obeth + CCl4 intoxicated groups was maintained b.wt. as the
control group (Table S4).
Serum Marker Enzymes
Effect of Obeth and CCl4 on SGOT, SGPT, and
ALP Levels
Group II (CCl4) significantly increased the amount of SGOT, SGPT,
and ALP to 351.45 ± 21.01, 133.86 ± 29.88, and 529.16 ± 56.74 IU/L
respectively in comparison with Group I (control) at 5% level of
significance (p ≤ 0.05) (Table S5). Increased concentration of these
enzymes in serum, highlighted the poor functioning of the liver and
liver injury because of their seepage into the blood. However, the
results showed that the treatment of Obeth minimized the amount
of these enzymes relative to the CCl4 Group II. III and IV exhibited
the amounts of SGOT, SGPT, and ALP in serum in the acceptable
limits, signifying reduction in liver injury (Figure 4A).
Direct Bilirubin and Total Bilirubin Enzymes in Obeth
and CCl4 Treated Rats
Obeth pretreatment followed by CCl4 doses in Groups V, VI, and
VII was effective in maintaining natural level of direct bilirubin
and total bilirubin disturbed in Group II (Figure 4B). In Group
III and Obeth treated Group VII indicated an optimum capacity
for regeneration by stopping a rise in these enzymes (Table S6).
Total Protein and Albumin Level in Serum
CCl4 stimulated changes in the hepatic enzymes resulting in
decreased albumin (2.15 ± 0.3 g/dL) and protein (5.93 ± 0.34 g/
dL) content that lead to hepatic injury (Table S7). Pretreatment
of Obeth followed by CCl4 intoxication exhibited substantial
protective capacity retaining the normal levels of these enzymes
as identified in Groups V, VI, and VII (Figure 4C).Frontiers in Pharmacology | www.frontiersin.org 9Effect of Obeth and CCl4 on Serum Proteins, Urea,
Creatinine, and Cholesterol
The levels of urea, creatinine and cholesterol in the serum of
various groups is given in Table S8. There was a significant
increase in the level of urea, creatinine and cholesterol in CCl4
treated Group II. As depicted from the results of Group IV
pretreated with Obeth followed by CCl4 showed a restored level
of urea, creatinine and cholesterol, hence showing the recovered
hepatic damage in a dose-dependent manner (Figure 4D).
Biochemical Parameters
Estimation of Protein Content in Liver Homogenate
The protein content in the CCl4-treated group (24.89 ± 4.16 mg/g
tissue) was observed to decrease significantly as compared to the
control group (52.74 ± 11.37 mg/g tissue) Table S9. Group IV,
however, showed a high protein content of 53.38 ± 4.21 mg/g. On
the other side, pretreated groups (V, VI, and VII) were shown to
greatly recover the normal protein amount as seen in Figure 5A.
Estimation of Lipid Peroxidation in
Liver Homogenate
The level of MDA content exhibited the level of lipid
peroxidation. Group II revealed a significant increase (p ≤
0.05) in the MDA content relative to the Group I. Group IV
Obeth treated exhibited less concentration of MDA content (0.67 ±
0.33 nM MDA equivalent/g of tissue). However, pretreatment of
Obeth followed by CCl4 resulted in a dose-dependent decrease in
raised MDA content as seen in Figure 5B and Table S9.
Estimation of Lipid Hydroperoxide in Liver Homogenate
It was observed that the group treated with CCl4 displayed a
substantial increase in the lipid hydroperoxide content (23.24 ±
2.54 nM equivalent H2O2/g of tissue) relative to the controlA B
DC
FIGURE 4 | Graph represents the effect of Obeth of O. bracteata on level of serum enzymes level in CCl4-treated male Wistar rats. (A) Represent the levels of
SGOT, SGPT, and ALP. (B) Represent the levels of direct bilirubin and total bilirubin. (C) Represent the levels of albumin and total protein. (D) Represent the levels of
urea, creatine and cholesterol. Values are expressed as Mean ± SE at level of significance p ≤ 0.05. Data labels with different letters represent significant difference
among them.August 2020 | Volume 11 | Article 1301
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Pretreatment by Obeth maximum dose showed to decrease
CCl4 toxic impact by exhibiting a maximal decrease in lipid
peroxide content (Figure 5C and Table S9).
Reduced Glutathione (GSH) Content
The group administered with silymarin displayed substantial
improvement in GSH content (209.75 ± 14.71 mmol of SH
content/g of tissue) compared with CCl4-treated group with
GSH content of 85.99 ± 9.57 mmol of SH content/g of tissue
(Table S9). Obeth recovered the reduced amount of GSH
effectively as close to that of the control group (Figure 5D).
Phase I Enzymes
As shown inTable S10,Obeth exhibited a dose-dependent effect on
cytochrome P450, b5 and P420 levels in the liver homogenate. CCl4-
treated group exhibited reduction in the level of cytochrome P450
(45.90 ± 5.07 mmol) and P420 (329.18 ± 26.63 mmol) as compared to
the control group. Pre-treatment of Obeth followed by CCl4,
showed increasing cytochrome levels P450 and P420 showing an
important defensive effect against hepatic toxicity (Figure 5E). A
rise in the production of cytochrome b5 (98.32 ± 5.74 mmol) in
CCl4 treated group compared to the control group (29.34 ± 2.27
mmol) was observed. NADH cytochrome P450 reductase activity
showed an increase in the CCl4-intoxicated group relative to the
control group. Silymarin (45.27 ± 1.91 mIU) and Obeth Group IV
(41.82 ± 3.23 mIU) showed same activity as compared to the
control group of rats (37.23 ± 2.96 mIU) whereas group VII
showed decrease in level of enzyme (32.47 ± 4.99 mIU) as
shown in Table S11. Moreover, the CCl4-treated group exhibitedFrontiers in Pharmacology | www.frontiersin.org 10an increase in the specific action of NADH cytochrome b5
reductase to 188.43 ± 3.86 mIU in comparison to the control
group (86.40 ± 3.17 mIU) whereas group VII exhibited
minimization in level of enzyme (67.20 ± 2.36 mIU) as shown in
(Figure 5G, Table S11).
Phase II Enzymes
Glutathione S-Transferase (GST)
CCl4 treated group showed decreased GST behavior (4.59 ±
0.684 mIU/mg protein) compared to the control group (7.6 ±
1.14 mIU) (Table S12) (Figure 5F). However, it was observed
that there was a significant increase in GST activity in group III,
IV, and VII which showed enhancement of hepatic antioxidant
enzymes to combat the increased level of reactive oxygen species.
Antioxidative Enzymes
Catalase
As shown in Table S13, the catalase activity decreased in the CCl4-
intoxicated group (21.92 ± 3.76 IU/mg protein) as compared to
control group (50.76 ± 1.95 IU/mg protein). The higher pretreated
dose of Obeth (200 mg/kg b.wt.) followed by CCl4 showed an
increase in catalase function over the untreated group, thereby
offering protective activity against CCl4 intoxication (Figure 5H).
Glutathione Reductase (GR)
The enzymatic expression of GR in the CCl4-administered group
showed 0.03 IU of GR level as compared to control group (0.09
IU). The increased GR specific activity was detected in groups VI
and VII which suggested Obeth has a protective role against




FIGURE 5 | Graph represents the effect of Obeth of O. bracteata on level of enzymes in CCl4-treated male Wistar rats. (A) Represent the levels of protein in liver
homogenates. (B) Represent the levels of malondialdehyde (MDA) content in liver homogenate. (C) Represent the levels of lipid hyperoxide in liver homogenates.
(D) Represent the levels of reduced glutathione (GSH) in liver homogenate. (E) Represent the levels of NADH Cyt b5 and NADH Cyt P450 in liver homogenate of
Wistar rats. (F) Represent the levels of GST in liver homogenate of Wistar rats. (G) Represent the levels of NADH Cyt b5 and NADH Cyt P450 in liver homogenate of
Wistar rats. (H) Represent the levels of Catalase in liver homogenate. (I) Represent the levels of lactate dehydrogenase and glutathione reductase in liver
homogenate. Values are expressed as Mean ± SE at level of significance p ≤ 0.05. Data labels with different letters represent significant difference among them.August 2020 | Volume 11 | Article 1301
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The level of lactate dehydrogenase is correlated with the integrity
of the cell membrane. The increased LDH level in the CCl4-
intoxicated group (0.03 IU) mediated cell injury occurred due to
the lethal metabolites created by Phase I and II enzyme
stimulation. Pre-treated groups with different doses of Obeth
were shown to significantly reduce the level of LDH equivalent to
the control group (Table S13) and (Figure 5I).
Histopathological Studies
The histopathological analysis showed supportive results for the
biochemical and serum enzyme markers. The liver of the CCl4-
treated group showed necrosis, inflammation and loss of
hepatocytes with vacuolization when observed between central
vein and portal traid area with hematoxylin and eosin staining
(Figure 6B). In Figure 6, compared to other groups, CCl4-
intoxicated group showed a maximum region of fibrotic markers
and collagen localization. Obeth and Silymarin treated groups
maintained normal liver hepatocyte architecture relative to
control group around the central vein area (Figures 6C–G).
Immunohistochemical (IHC) Analysis
Within hepatocytes, over-expression of p53 protein and cyclin-D
contribute to hepatocellular carcinoma development. In this
experiment, CCl4-treated group exhibited an upregulated
expression level of cyclin D (Figure 7A) and p53 markers (Figure
7B) which finally show fibrosis and lobular inflammation whereas,
treatment of Obeth decreased the CCl4 induced p53 and cyclin D
protein expression dose-dependently in liver hepatocytes as
compared to the toxic group (Figures 7A, c–g and 7B, c–g).
Comet Assay
As shown in Figure 8, larger Comet tail length in CCl4 treated
groups indicated the higher necrosis, apoptosis and DNA
fragmentation in hepatocytes. Whereas, reduced Comet tailFrontiers in Pharmacology | www.frontiersin.org 11length in Obeth + CCl4 treated groups (100 mg/kg b.wt. and
200 mg/kg b.wt.) showed inhibition of necrosis, apoptosis and
DNA fragmentation.
Western Blotting
Protein Expression of p-53, Cox-2, and NfkB
To explore the relationship between p53, COX-2, and NfkB and
the hepatoprotective effects ofObeth on toxicity induced by CCl4,
we studied protein expression using western blotting. As shown
in Figure 9. there was a significant increased (p < 0.05) in p53,
Cox-2, and NfkB protein expression in CCl4 treated group as
compared to the untreated control group. However, there was a
dose-dependent decrease in the expression of proteins on
administration of Obeth with CCl4 treated groups as compared
to only CCl4 intoxicated group.
Phytochemical Analysis by HPLC Analysis
The phytochemical analysis by HPLC exhibited the occurrence
of catechin, epicatechin, Onosmin A, rutin and kaempferol as
major phytoconstituents in Obeth (Figure 10, Table 2).DISCUSSION
The active polyphenols present in the plants act as scavengers of
ROS, DNA protective agents and help to maintain the expression
of genes/proteins that break down toxins and keep cellular redox
homeostasis (Liu et al., 2018). These polyphenols have the
antioxidant, antimutagenic and chemopreventive properties
that might help to protect and conserve the constancy of
genome (Mehta et al., 2010; Rodrıǵuez-Garcıá et al., 2019).
Previous studies have reported the potential of Onosma genus
as antioxidant compounds and their use in averting numerous
pharmacological situations (Naz et al., 2006; Ebrahimzadeh et al.,
2010; Ahmad et al., 2013; Imran et al., 2018; Farooq et al., 2019).A B D
E F G
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FIGURE 6 | Effect of Obeth from O. bracteata on histology of liver tissues as assessed by H & E staining. (A) Control group (tap water ad libitum) (GI) showing
normal lobular architecture with clear portal triad. (B) CCl4: Olive oil (1:1; 1mL kg
-1b.wt.) induced necro-inflammatory activity in GII was noted. Treatment of Obeth
extract was associated with diminution of portal hypertension with increasing dose. (C) Silymarin (100 mg kg-1b.wt.) + CCl4, (D) low dose (50 mg kg
-1b.wt.) + CCl4,
(E) medium dose (100 mg kg-1b.wt.) + CCl4, (F) High dose (200 mg kg
-1b.wt.) + CCl4, (G) Negative (only extract 100 mg kg
-1b.wt. Arrows indicate Kupffer cell (KC),
central vein (CV), hepatic cells (HC), blood sinusoids (BS), steatosis (S) (black arrow), and necrosis (N) (red arrow).August 2020 | Volume 11 | Article 1301
Kumar et al. Hepatoprotective Effects of Onosma bracteata WallIn the current study, we investigated the antioxidant,
antimutagenic, genoprotective, and hepatoprotective properties
of Obeth from Onosma bracteata along with evaluation of the
expression of proteins involved in the inflammation and
apoptotic induction in in vivo studies using male Wistar rats.
In antioxidant assays, Obeth had shown potential to scavenge
free radicals, namely in SRS and LPO assays. Obeth showed
strong radical scavenging activity with EC50 (115.14 μg/mL)
whereas LPO inhibition activity with EC50 (199.33 μg/mL)
(Tables S1 and S2). Radical scavenging potential of Obeth
might be correlated to the nature of phenolics, contributing to
their electron transfer/hydrogen donating ability.Frontiers in Pharmacology | www.frontiersin.org 12Plants contain natural antioxidants, primarily flavonoids,
which are being explored to inhibit various diseases viz.
chronic inflammation and cancer (Surh, 2003). Onosma genus
plants are enriched with bioactive components viz. flavonoids,
alkannin, and shikonin responsible for wound healing, analgesic
and its antibacterial actions (Kumar et al., 2013). The HPLC
analysis ofObeth revealed the existence of different phytoconstituents
viz., kaempferol, Onosmin A, catechin and epicatechin. Numerous
reports have shown that Onosma genus and its isolated compounds
are responsible for excellent antioxidant activities (Riedl et al., 2004;
Kandemir and Türkmen, 2008; Menghani et al., 2011). The ethyl
acetate, methanol and water extracts from Onosma heterophyllaA B D E F GC
FIGURE 8 | Single cell gel electrophoresis assay was used for determined DNA damage/protect in liver of rats. Results of the comet assay confirm that
pretreatment with Obeth decreases CCl4-induced hepatotoxicity in rats. (A) Control group (tap water ad libitum) (GI), (B) CCl4: Olive oil (1:1; 1mL kg
-1b.wt.) in GII,
(C) Silymarin (100 mg kg-1b.wt.) + CCl4, (D) low dose (50 mg kg
-1b.wt.) + CCl4, (E) medium dose (100 mg kg
-1b.wt.) + CCl4, (F) High dose (200 mg kg
-1b.wt.) +
CCl4, (G) Negative (only extract 100 mg kg
-1b.wt.). Histograms showing densitometric analysis of % of DNA in tail in comet assay. Values are expressed as Mean ±
SE at level of significance p ≤ 0.05. Data labels with different letters represent significant difference among them.A
B
FIGURE 7 | Effect of Obeth from O. bracteata on expression levels of proteins using immunohistochemical analysis of liver tissues. (A) shows cyclin (d) and
(B) shows p53 antibodies. Arrows showed the increase in expression of cyclin D and p53 proteins in CCl4 treated liver samples (Original magnification = 40 x).
Expression of these proteins was downregulated when observed in liver samples co-treated with CCl4 and Obeth (200 mg/kg b.wt.). Red arrow indicates the
increase in the expression of protein in the CCl4 treated group. (b) Control group (tap water ad libitum) (GI) showing normal lobular architecture with clear portal triad.
(b) CCl4: Olive oil (1:1; 1mL kg
-1 b.wt.) induced elevation in the expression level of cyclin D was noted. Treatment of Obeth extract was associated with diminution of
portal hypertension with increasing dose. (c) Silymarin (100 mg kg-1b.wt.) + CCl4, (d) low dose (50 mg kg
-1b.wt.) + CCl4, (e) medium dose (100 mg kg
-1b.wt.) + CCl4,
(f) High dose (200 mg kg-1b.wt.) + CCl4, (g) Negative (only extract 100 mg kg
-1 b.wt.).August 2020 | Volume 11 | Article 1301
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Coumaric acid, rutin and rosmarinic acid which are responsible for
antioxidant activity (Ozer et al., 2018). Saravanakumar et al., 2019
also reported that the methanol extract of Onosma isaurica Boiss. &
Heldr. and Onosma bracteosa Hausskn. & Bornm. showed effectiveFrontiers in Pharmacology | www.frontiersin.org 13free radical scavenging ability due to the presence of the
phytoconstituents. This plant has been widely used because of its
medicinal properties.
In Ames assay, the antimutagenic potential of Obeth against
sodium azide, 4-nitro-o-phenylenediamine and 2- aminofluorene
mutagens was evaluated against two Salmonella typhimurium
strains, i.e., TA100 and TA98. The study showed that Obeth
effectively modulated the mutagenicity of direct-acting base-pair
mutagen, sodium azide with 82.30% inhibition at 250 mg/0.1 mL/
plate (Table S3) in TA 100 while it showed moderate
antimutagenic effect against 4NPD with 62.85% inhibition at the
same concentration in TA98 tester strain. Obeth exhibited
antimutagenicity against 2AF (S9 dependent) in both the tester
strains. Kaur et al., 2001 reported that phenolic fractions isolated
from Terminalia arjuna showed mutagen specificity via
decreasing the frameshift mutagen NPD whereas it failed in the
prevention of sodium azide (base pair substitution)-induced his+
revertants. Kaur et al., 2016 described that ethyl acetate fraction of
Cassia fistula (CaFE) showed strong antimutagenic and antioxidant
properties due to the presence of polyphenolic compoundsFIGURE 10 | Chromatogram of Obeth of O. bracteata showing presence of polyphenols as identified using HPLC analysis by reference compound.TABLE 2 | Amount (mg/L) of different phytochemical quantified by HPLC in
different Obeth of O. bracteata.
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FIGURE 9 | Expression level p53, NFkB, and COX-2 protein in liver homogenate of Wistar rats detected using Western blotting. (A) Control group (tap water ad
libitum) (GI), (B) CCl4: Olive oil (1:1; 1mL kg
-1b.wt.) induced elevation in the expression level of p53 was noted. (C) Silymarin (100 mg kg-1b.wt.) + CCl4, (D) low dose
(50 mg kg-1b.wt.) + CCl4, (E) medium dose (100 mg kg
-1b.wt.) + CCl4, (F) High dose (200 mg kg
-1b.wt.) + CCl4, (G) Negative (only extract 100 mg kg
-1 b/wt.).
Histograms showing densitometric analysis of p53, NFkB, and COX-2 protein bands using western blotting. Band density was measured and normalized to that of
b-actin. Values are expressed as mean ± SE at level of significance p ≤ 0.05. Data labels with different letters represent significant difference among them.August 2020 | Volume 11 | Article 1301
Kumar et al. Hepatoprotective Effects of Onosma bracteata Wall(umbelliferone, catechin and epicatechin). Obeth also demonstrated
the potential to protect plasmidDNA against free radicals of Fenton’s
reagent in plasmid DNA nicking assay. Obeth at 100 μg/mL
concentration efficiently retained DNA’s supercoiled form.
In in vivo studies, serum analysis showed that the oxidative
stress serum markers (SGOT, SGPT, ALP, creatinine and direct
bilirubin) were significantly increased, following the dosage of
CCl4 to rats (Group II) (Tables S5, S6, and S8). The potential to
produce albumin proteins (which function as transport
molecules) vanished in damaged hepatocytes, and the capacity
to make inflammatory proteins increased. CCl4 generated free
radicals (trichloromethyl and peroxytrichloromethyl) that
induced damage in hepatocytes resulting in leakage of
cytoplasmic SGPT and SGOT into the bloodstream (Shah
et al., 2015). Obeth ameliorated the toxic effects of CCl4 by
enhancing the activity of antioxidant molecules in the liver.
Obeth significantly decreased the damage caused by CCl4
(Group II) in cellular TBARS. A decrease in GSH enzymes and
protein levels was observed in the CCl4 treated group (Group II),
while an increase in these markers was observed following Obeth
treatment (Table S9). Sabir et al. (2017) reported in their study
that aqueous extracts of Zanthoxylum armatum DC. (syn.
Zanthoxylum alatum Roxb.) restored the level of glutathione
and showed hepatoprotective property against paracetamol-
induced hepatic damage in albino mice which decreased the
hepatic glutathione level. The activation of lipid hydroperoxides,
Cytochrome P450, P420, and b5 were observed in CCl4 treated
group whereas Obeth treatment declined the level of these
markers (Table S10). The values of the above parameters in
theObeth-treated group were the same as of the control (GroupI)
which reflects a high safety potential of Obeth. CCl4 treated
group showed decline GST levels as compared to control but in a
dose-dependent manner whereas Obeth treated groups exhibited
restored level of GST. Allocati et al., 2018 reported that GSTs can
protect DNA against oxidative stress and eliminate toxic
molecules that can led to mutations or carcinogenesis. Laouar
et al., 2017 reported that treatment of CCl4 lead to significantly
reduced levels of hepatic GSH, GPx, and GST activities than
control group in Wistar rats, whereas aqueous extract of
Juniperus phoenicea L. berries treatment significantly restored
the levels of these enzymes. The Group II showed a significant
increase in the amount of NADPH cytochrome b5 and NADH
cytochrome 450, whereas, Obeth treated groups exhibited a dose-
dependent decline in the level of these enzymes (Table S11). The
CCl4 treatment generates CCl3
• radicals which not only damaged
DNA but also caused necrosis and apoptosis as evidenced from
increase in Comet tail length in CCl4 treated group whereas in
case of Obeth -treated groups, the reduced Comet tail length
showed the DNA protective activity of Obeth in a dose-
dependent manner (Figure 8). Damage of cells by CCl3
• free
radical (toxic) formed by the reduction of CCl4, in hepatocytes
has also been reported Brai et al. (2014) and Josan et al. (2015).
The previous report from Younis et al., 2018 showed that CCl4
treated rats showed a high degree of DNA damage and
remarkable changes in (comet, head, tail) length and %DNA in
the tail, while methanolic extract of Fraxinus xanthoxyloidesFrontiers in Pharmacology | www.frontiersin.org 14(G.Don) Wall. ex A.DC. ameliorates the effect of CCl4 similar to
that of control group.
Histopathological studies showed that Obeth was itself non-
toxic and showed close histological similarity to the control
group and displayed the same histological arrangement with
no sign of inflammation (Figure 6G). In contrast, CCl4
treated group displayed steatosis, necrosis, inflammation in
blood sinusoids and vacuolization (Figure 6B). However,
pretreatment of Obeth followed by CCl4 treatment effectively
restored the regular hepatocytes’ architecture and also reduces
the vacuoles formation between the central vein and portal triad
indicating hepatoprotective potential of Obeth, as shown in
Figures 6D–F. Earlier, Josan et al. (2015) reported that CCl4
treated Sprague Dawley rats showed necrosis of hepatocytes
nearby central vein and increased the level of alanine
transaminase (ALT) whereas control group showed normal
architecture of hepatocytes. Ganaie et al., 2015 also reported
that dose-dependent treatment of ethanolic extract of Rumex
vesicarius L. showed a restored pattern of histological
architecture, while silymarin treatment followed by CCl4-
intoxication in Wistar rats showed less disarrangement of
hepatocytes. The results of the Immunohistochemistry (IHC)
studies showed that p53 protein and Cyclin D expressions in the
liver tissues were maximum in the CCl4 intoxicated group.
Upregulated expression of pro-apoptotic p53 in CCl4 treated
group might be formed in response to hepatocyte inflammation
and the induction of necrosis in liver cells (Figures 7A, B).
Similar results were observed in western blotting studies showing
p53 upregulation in the CCl4 group as compared with the control
group. The tumor suppressor gene p53 is upregulated in
response to DNA damage, and its upregulated expression is
only found in cells that show mutant forms (Aly et al., 2019). The
upregulated expression of Cyclin D protein in the CCl4
intoxicated group also highlighted the mutation in hepatocytes
while Obeth treatment showed the downregulation of Cyclin D
exhibiting its protective effects against CCl4 intoxication. Cyclin
D has been described to have the main role in cell progression
through the G1/S phase of the cell cycle, and its deregulation can
lead to tumorigenesis (Ying et al., 2008; Chibazakura et al., 2011;
Gao et al., 2016).
The expression of p53, COX-2, and NF-kB was upregulated
due to cellular stress, inflammation and mutation in cellular
DNA (Banerjee et al., 2002; Cha and DeMatteo, 2005). Hepatic
cancer can be controlled by the suppression of COX-2, NF-kB
and p53 which might offer an effective control approach. The
investigation of the effects of Obeth towards stimulated forms of
p53, cyclin-D, COX-2 and NF- kB proteins was performed. The
expression levels of COX-2 and NF-kB proteins were
upregulated after CCl4 administration (Figure 9) highlighting
the production of mediator cytokines which facilitate tumor
growth via inhibiting apoptosis and promoting cell
proliferation (Brücher et al., 2019; Lerdwanangkun et al.,
2019). Eltahir et al. (2020) reported that CCl4 treated Wistar
rats showed significantly high expression levels of NF- kB and
COX-2 while Boswellia serrata Roxb. (BS) gum resin treatment
followed by CCl4 significantly restored the level of NF- kB andAugust 2020 | Volume 11 | Article 1301
Kumar et al. Hepatoprotective Effects of Onosma bracteata WallCOX-2 expression due to the presences of a natural compound
that exhibited anti-inflammatory effects by targeting multiple
pathways. The stressed cells promoted the overactivation of
signaling proteins or inflammatory cytokines including, IL-6,
TNFa, and IL-1b that stimulate the overproduction of IL-6 in
Kupffer cells leading to the enhanced proliferation of hepatocytes,
some of which harbor oncogenic mutations (Sun and Karin, 2008).
Obeth has efficient antioxidant properties that protect the
hepatocytes against any damage by inducing antioxidative
mechanisms. Previous reports have proved the connotation
among natural compounds isolated from plants and cancer
inhibition via antioxidant properties (Seufi et al., 2009). In the
present study, it was found that the Obeth contains catechin,
epicatechin, rutin, kaempferol, and Onosmin A (Figure 10,
Table 2). All these compounds have antioxidant potential are
known to ascertain their remedial effects by scavenging the free
radical species due to the presence of H donating hydroxyl groups
on the different polyphenolic rings of these molecules stabilize the
negative charge on the different reactive species and hence, nullify
their damaging consequences (Kaur P. et al., 2019). One such study
showed catechin to regulate the expression of NF-kB and Cox-2 by
scavenging the ROS and hence delivering the anti-inflammatory
and antioxidant effects (Chu et al., 2017). Similarly, rutin has also
proven as an effective hepatoprotective agent against CCl4 induced
Wistar rat liver damage by altering the expression of IL-6/STAT3
pathway genes expression due to its antioxidative, anti-
inflammatory and anti-apoptotic properties (Hafez et al., 2015).
On the other hand, epicatechin has the potential to inhibit Sprague-
Dawley rat liver inflammation via NFkB signaling pathway
initiated by HSP60 (Huang et al., 2019). Zang et al., 2018
reported that soybean leaves and its isolated compound
kaempferol galactoside and kaempferol have the ability to reduce
serum parameters (serum aspartate aminotransferase and serum
alanine aminotransferase) increased by CCl4 intoxication. InFrontiers in Pharmacology | www.frontiersin.org 15addition to this, all these compounds were also found to
ameliorate the lipid peroxidation and regulate the levels of
different liver enzymes (Sinha et al., 2012; Khan et al., 2012; Liu
et al., 2015; Wang et al., 2015). The polyphenolics such as catechin,
caffeine, epicatechin (EC), epigallocatechin gallate (EGCG), and
epicatechin gallate (ECG) showed preventive effects of Liubao Tea
against CCl4 -induced liver injury in Kunming mice, comparable to
silymarin (Pan et al., 2018). Ahmad et al., 2005, reported that
Onosmin A isolated from Onosma hispida Wall. ex G.Don has
potential to inhibit lipogenase enzyme in a concentration-
dependent manner. It can be stated that the chemical association
of phytochemicals, presumable flavonoids in Obeth from O.
bracteata have protective effects on liver damage via suppression
of CCl4-induced oxidative stress (Figure 11). This study reported
that antioxidant, antimutagenic, DNA protective, and anti-
inflammatory properties of Obeth are correlated with the
phytoconstituents present in and have also been shown to have
modulatory impact on pro-carcinogenic proteins p53, NF-kB, and
COX-2 for the first time.CONCLUSIONS
In the current study, Obeth of O. bracteata has shown significant
antioxidant, genoprotective, antimutagenic and hepatoprotective
properties. As revealed by HPLC investigations, Obeth harbors
catechin, epicatechin, rutin, Onosmin A and kaempferol as major
phytoconstituents. Obeth exerted its protective potential via its
radical scavenging and DNA protective abilities, minimizing
oxidative stress through induction of antioxidative enzymes and
ameliorating the hepatic changes triggered by CCl4. Themodulation
of crucial proteins such as p53, cyclin D, Cox-2, and NF-kB
demonstrated potential of Obeth as an effective chemotherapeutic
agent against hepatic cancer.FIGURE 11 | Schematic proposed mechanisms for hepatoprotective property of Obeth from O. bracteata. Obeth phytoconstituents ameliorated hepatic oxidative
stress and suppressed inflammation, apoptosis, and DNA damage in CCl4-injured hepatocytes.August 2020 | Volume 11 | Article 1301
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